Atlas Trials

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Clinical trial NCT00978237 · COMPLETED

Trial details

NCT number
NCT00978237
Sponsor
Juan A. Arnaiz
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsLipoatrophy
Start date
2009-10-01
Primary completion
2013-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.